FusionPlex® Sarcoma v2

The FusionPlex® Sarcoma v2 panel is a targeted next-generation sequencing (NGS) research product that expands on FusionPlex® Sarcoma panel. The updated design covers key fusions and variants in 63 genes relevant in sarcomas.

FusionPlex® uses RNA instead of DNA as input material, which allows for more accurate and more cost-effective fusion detection than DNA-based hybrid capture techniques. FusionPlex® places gene-specific primers near known fusion breakpoints to identify RNA abnormalities with a single primer. Because FusionPlex® can identify known and novel alterations with a limited number of primers, it can detect fusions more efficiently and accurately than DNA-based approaches.

Archer Analysis software allows the analysis and interpretation of the NGS data.

Comprehensive Fusion Detection

AMP™ chemistry utilizes open-ended targeted amplification to identify gene fusions whether or not the fusion partner is known.

Quiver® Fusion Database

Powerful fusion analysis combined with a curated database of relevant known translocations.

Low Input

Purpose-built for wide sample type compatibility, including low-input and degraded samples such as FFPE tissue.

Simple Workflow, Lyophilized Reagents

Easy-to-handle lyophilized reagents and a simple workflow to minimize errors and reduce turn-around time.